Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in High-Risk Cardiac Surgery (SIRS)
NCT00427388Phase 4Unknown
- Sponsor
- Population Health Research Institute
- Start
- Jun 2007
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone injection in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Population Health Research Institute. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT00427388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427388.